Data from Federal Scientists Raise Questions About J. & J. Booster Shots
People who have received the company ’s one-shot vaccine may benefit from a booster with another brand. F.D.A. advisers will discuss the data on Friday.
Source: NYT Health - Category: Consumer Health News Authors: Carl Zimmer and Noah Weiland Tags: Vaccination and Immunization Coronavirus Delta Variant Coronavirus (2019-nCoV) Johnson & Pfizer Inc Clinical Trials Food and Drug Administration Moderna Inc Research United States Politics and Government National Institutes of Health Source Type: news
More News: Clinical Trials | Coronavirus | COVID-19 | Food and Drug Administration (FDA) | Government | Health | National Institutes of Health (NIH) | Pfizer | Politics | USA Health | Vaccines